Skip to main content

ADVERTISEMENT

Ricardo A. Costa, MD, PhD

Original Contribution
08/25/2015
The use of the Svelte Acrobat Integrated Delivery System via radial approach with 5 Fr catheters is evaluated for safety and efficacy. In this 50-patient study, the authors show that this direct stenting system enables easy delivery,...
The use of the Svelte Acrobat Integrated Delivery System via radial approach with 5 Fr catheters is evaluated for safety and efficacy. In this 50-patient study, the authors show that this direct stenting system enables easy delivery,...
The use of the Svelte Acrobat...
08/25/2015
Journal of Invasive Cardiology
Original Contribution
02/28/2017
This prospective, placebo-controlled trial was conducted in diabetic patients randomized (1:1) to receive either standard DAPT vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent.
This prospective, placebo-controlled trial was conducted in diabetic patients randomized (1:1) to receive either standard DAPT vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent.
This prospective,...
02/28/2017
Journal of Invasive Cardiology
Original Contribution
05/31/2017
The present study examined the association between Multicenter CTO Registry in Japan (J-CTO) score in predicting failure of percutaneous coronary intervention correlating with the estimated duration of chronic total occlusion.
The present study examined the association between Multicenter CTO Registry in Japan (J-CTO) score in predicting failure of percutaneous coronary intervention correlating with the estimated duration of chronic total occlusion.
The present study examined the...
05/31/2017
Journal of Invasive Cardiology
Original Contribution
06/15/2017
We sought to assess the outcomes of patients treated with second-generation drug-eluting stent classified according to the updated American College of Cardiology Foundation/American Heart Association/Society for Cardiac Angiography and...
We sought to assess the outcomes of patients treated with second-generation drug-eluting stent classified according to the updated American College of Cardiology Foundation/American Heart Association/Society for Cardiac Angiography and...
We sought to assess the outcomes...
06/15/2017
Journal of Invasive Cardiology
Original Contribution
05/01/2023
In this study, the authors assessed the vessel-healing pattern of the sirolimus-eluting Inspiron DES using serial optical coherence tomography, assuming that this thin-strut, biodegradable-polymer DES promotes a faster healing.
In this study, the authors assessed the vessel-healing pattern of the sirolimus-eluting Inspiron DES using serial optical coherence tomography, assuming that this thin-strut, biodegradable-polymer DES promotes a faster healing.
In this study, the authors...
05/01/2023
Journal of Invasive Cardiology
Original Contribution
05/16/2023
Despite the potential benefits of percutaneous procedures for the assessment and treatment of coronary artery disease, these interventions require the use of iodine contrast, which might lead to contrast-induced nephropathy (CIN) and...
Despite the potential benefits of percutaneous procedures for the assessment and treatment of coronary artery disease, these interventions require the use of iodine contrast, which might lead to contrast-induced nephropathy (CIN) and...
Despite the potential benefits...
05/16/2023
Journal of Invasive Cardiology
Cardiovascular Risk Stratification for Patients Treated With Drug-Eluting Stents: Development and Validation of the DESIRE Score
Original Contribution
03/01/2020
We developed a risk score to estimate the risk of major adverse cardiac event (MACE) during the in-hospital and long-term follow-up periods after PCI with drug-eluting stent (DES) implantation.
We developed a risk score to estimate the risk of major adverse cardiac event (MACE) during the in-hospital and long-term follow-up periods after PCI with drug-eluting stent (DES) implantation.
We developed a risk score to...
03/01/2020
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Despite the recent advent of drug-eluting stents (DES), preparation of complex lesions (e.g., ostial, diffuse, fibrocalcified lesions and in-stent restenosis) before stent implantation remains an essential component of percutaneous coronary...
Despite the recent advent of drug-eluting stents (DES), preparation of complex lesions (e.g., ostial, diffuse, fibrocalcified lesions and in-stent restenosis) before stent implantation remains an essential component of percutaneous coronary...
Despite the recent advent of...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
09/10/2008
ABSTRACT: Background. Despite the increasing number of elderly people, this high-complexity subset of patients is often excluded from randomized trials of percutaneous coronary intervention (PCI) and, therefore, limited data are available...
ABSTRACT: Background. Despite the increasing number of elderly people, this high-complexity subset of patients is often excluded from randomized trials of percutaneous coronary intervention (PCI) and, therefore, limited data are available...
ABSTRACT: Background. Despite...
09/10/2008
Journal of Invasive Cardiology
Review
08/01/2008
Treatment of bifurcation lesions has been associated with lower success and higher complications rates. They represent a major interventional challenge. Redistribution of plaque (snowplow effect) often leads to occlusion of the side branch....
Treatment of bifurcation lesions has been associated with lower success and higher complications rates. They represent a major interventional challenge. Redistribution of plaque (snowplow effect) often leads to occlusion of the side branch....
Treatment of bifurcation lesions...
08/01/2008
Journal of Invasive Cardiology